The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…
“Markets may have crashed into bear territory last week, but with every fall in prices comes an opportunity – to buy in at a discount,”…
While investors dump stocks in sectors getting hit hardest by coronavirus fears, insiders at various companies in those sectors are buying up their own companies’…
Insiders don’t have to buy shares of their respective companies – so it can pay to follow their lead when they do. As the author…